Novartis(NVS) Exploring Options To Divest $25+ Billion Eye-Care Unit

Swiss pharmaceutical giant Novartis (NVS) is considering a spin off Alcon, its surgical equipment and contact lens business. While most of its peers are busy acquiring each other, Novartis is taking a more inward-focused approach also announcing today a $5 billion share buyback. Reporting its 2016 earnings, Novartis said: “Novartis is considering options for the Alcon Division. The… Read More »